NO20065422L - Avlevering av anti-sopplegemiddel - Google Patents
Avlevering av anti-sopplegemiddelInfo
- Publication number
- NO20065422L NO20065422L NO20065422A NO20065422A NO20065422L NO 20065422 L NO20065422 L NO 20065422L NO 20065422 A NO20065422 A NO 20065422A NO 20065422 A NO20065422 A NO 20065422A NO 20065422 L NO20065422 L NO 20065422L
- Authority
- NO
- Norway
- Prior art keywords
- alcohol
- fungal
- skin
- nails
- aliphatic alcohol
- Prior art date
Links
- 239000003429 antifungal agent Substances 0.000 title 1
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 abstract 8
- 230000000843 anti-fungal effect Effects 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 5
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 4
- 229940121375 antifungal agent Drugs 0.000 abstract 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 3
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 2
- 208000031888 Mycoses Diseases 0.000 abstract 2
- 239000012871 anti-fungal composition Substances 0.000 abstract 2
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000011877 solvent mixture Substances 0.000 abstract 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 abstract 1
- 229960002722 terbinafine Drugs 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/832,933 US20050238672A1 (en) | 2004-04-27 | 2004-04-27 | Antifungal drug delivery |
| PCT/US2005/014246 WO2005105072A2 (en) | 2004-04-27 | 2005-04-25 | Antifungal drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065422L true NO20065422L (no) | 2007-01-19 |
Family
ID=35136720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065422A NO20065422L (no) | 2004-04-27 | 2006-11-24 | Avlevering av anti-sopplegemiddel |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050238672A1 (enExample) |
| EP (1) | EP1755575A4 (enExample) |
| JP (1) | JP2007534764A (enExample) |
| KR (1) | KR20070024543A (enExample) |
| CN (1) | CN101022779B (enExample) |
| AU (1) | AU2005237541A1 (enExample) |
| BR (1) | BRPI0510286A (enExample) |
| CA (1) | CA2564134A1 (enExample) |
| IL (1) | IL178750A0 (enExample) |
| MX (1) | MXPA06012426A (enExample) |
| NO (1) | NO20065422L (enExample) |
| RU (1) | RU2006141653A (enExample) |
| WO (1) | WO2005105072A2 (enExample) |
| ZA (1) | ZA200609821B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0506139D0 (en) * | 2005-03-24 | 2005-05-04 | Transphase Ltd | A transdermal topical composition and its uses |
| MXPA05012961A (es) * | 2005-11-30 | 2007-05-30 | Fernando Ahumada Ayala | Preparaciones para el cuidado de las unas que contienen clorhidrato de terbinafina. |
| US20090215888A1 (en) * | 2006-03-02 | 2009-08-27 | Singh Jagat | Topical nail formulation |
| WO2008102349A2 (en) * | 2007-02-21 | 2008-08-28 | Power Paper Ltd | Terbinafine formulation for iontophoresis |
| GB201011212D0 (en) * | 2010-07-02 | 2010-08-18 | Linde Aktiengesellshcaft | Gas storage apparatus |
| KR20120056314A (ko) * | 2010-11-24 | 2012-06-04 | 주식회사유한양행 | 테르비나핀 또는 그의 염을 함유하는 국소 항진균 조성물 |
| EP2906197A1 (en) | 2012-10-09 | 2015-08-19 | The Procter & Gamble Company | Method of identifying synergistic cosmetic combinations |
| EP2906946A1 (en) | 2012-10-09 | 2015-08-19 | The Procter & Gamble Company | Method of identifying or evaluating beneficial actives and compositions containing the same |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| US9144538B2 (en) | 2013-02-08 | 2015-09-29 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin |
| US9138393B2 (en) | 2013-02-08 | 2015-09-22 | The Procter & Gamble Company | Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin |
| GB201317005D0 (en) * | 2013-09-25 | 2013-11-06 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| EP2952208A1 (en) * | 2014-06-04 | 2015-12-09 | Universidade de Santiago de Compostela | Hydroalcoholic system for nail treatment |
| CA3034839A1 (en) * | 2016-08-29 | 2018-03-08 | Carl F. Schanbacher | Methods and compositions for treating cutaneous fungal infections |
| US11554108B2 (en) | 2016-08-29 | 2023-01-17 | Xeropedix, Inc. | Methods and compositions for treating cutaneous fungal infections |
| RU2699653C1 (ru) * | 2019-03-22 | 2019-09-09 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) (ФГАОУ ВО Первый МГМУ им. И.М. Сеченова Минздрава России (Се | Средство для лечения микоза ногтей |
| EP4041839A4 (en) * | 2019-10-08 | 2023-10-11 | Hallux, Inc. | ONYCHOMYCOSIS TREATMENT COMPOSITIONS AND METHODS |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3382151A (en) * | 1964-01-13 | 1968-05-07 | Mavala Sa | Composition for strengthening nails |
| DE3544983A1 (de) * | 1985-12-19 | 1987-06-25 | Hoechst Ag | Antimykotisch wirksamer nagellack |
| US4820724A (en) * | 1986-03-31 | 1989-04-11 | University Of Southern California | Dual phase solvent carrier system |
| US4894375A (en) * | 1986-09-29 | 1990-01-16 | Merck & Co., Inc. | Method of controlling mycotic infections and compositions therefor |
| FR2673537B1 (fr) * | 1991-03-08 | 1993-06-11 | Oreal | Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes. |
| US5487776A (en) * | 1994-03-17 | 1996-01-30 | Nimni; Marcel | Anti-fungal nail lacquer and method therefor |
| US5696164A (en) * | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
| US5652256A (en) * | 1995-06-06 | 1997-07-29 | Knowles; W. Roy | Topical composition for fungal treatment |
| US5814308A (en) * | 1996-03-26 | 1998-09-29 | Zhang; Ke | Methods for the treatment of gastrointestinal tract disorders |
| US6030948A (en) * | 1997-12-19 | 2000-02-29 | Mann; Morris A. | Hair regeneration compositions for treatment of alopecia and methods of application related thereto |
| US6224887B1 (en) * | 1998-02-09 | 2001-05-01 | Macrochem Corporation | Antifungal nail lacquer and method using same |
| ATE269067T1 (de) * | 1998-04-17 | 2004-07-15 | Bertek Pharm Inc | Topische formulierungen zur behandlung von nagel pilzerkrankungen |
| US6495124B1 (en) * | 2000-02-14 | 2002-12-17 | Macrochem Corporation | Antifungal nail lacquer and method using same |
| US6281239B1 (en) * | 2000-04-12 | 2001-08-28 | Bradley Pharmeaceuticals, Inc. | Method of treating onychomycosis |
| US6585963B1 (en) * | 2001-02-15 | 2003-07-01 | Watson Pharmaceuticals, Inc. | Nail compositions and methods of administering same |
| GB0108082D0 (en) * | 2001-03-30 | 2001-05-23 | Novartis Consumer Health Sa | Topical composition |
| US6765001B2 (en) * | 2001-12-21 | 2004-07-20 | Medicis Pharmaceutical Corporation | Compositions and methods for enhancing corticosteroid delivery |
| EP1635770B1 (en) * | 2003-03-21 | 2009-05-27 | Nexmed Holdings, Inc. | Antifungal nail coat and method of use |
| US20040191207A1 (en) * | 2003-03-31 | 2004-09-30 | Lipari John M. | Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| HUP0303313A2 (hu) * | 2003-10-09 | 2005-07-28 | Richter Gedeon Vegyészeti Gyár Rt. | Transzdermális gyógyszerkészítmények |
-
2004
- 2004-04-27 US US10/832,933 patent/US20050238672A1/en not_active Abandoned
-
2005
- 2005-04-25 CN CN2005800133411A patent/CN101022779B/zh not_active Expired - Fee Related
- 2005-04-25 AU AU2005237541A patent/AU2005237541A1/en not_active Abandoned
- 2005-04-25 RU RU2006141653/15A patent/RU2006141653A/ru not_active Application Discontinuation
- 2005-04-25 ZA ZA200609821A patent/ZA200609821B/xx unknown
- 2005-04-25 EP EP05739804A patent/EP1755575A4/en not_active Withdrawn
- 2005-04-25 MX MXPA06012426A patent/MXPA06012426A/es not_active Application Discontinuation
- 2005-04-25 JP JP2007510881A patent/JP2007534764A/ja active Pending
- 2005-04-25 WO PCT/US2005/014246 patent/WO2005105072A2/en not_active Ceased
- 2005-04-25 CA CA002564134A patent/CA2564134A1/en not_active Abandoned
- 2005-04-25 KR KR1020067024858A patent/KR20070024543A/ko not_active Withdrawn
- 2005-04-25 BR BRPI0510286-3A patent/BRPI0510286A/pt not_active IP Right Cessation
-
2006
- 2006-10-19 IL IL178750A patent/IL178750A0/en unknown
- 2006-11-24 NO NO20065422A patent/NO20065422L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1755575A4 (en) | 2010-09-22 |
| BRPI0510286A (pt) | 2007-10-30 |
| WO2005105072A3 (en) | 2006-03-02 |
| US20050238672A1 (en) | 2005-10-27 |
| EP1755575A2 (en) | 2007-02-28 |
| JP2007534764A (ja) | 2007-11-29 |
| KR20070024543A (ko) | 2007-03-02 |
| IL178750A0 (en) | 2007-05-15 |
| AU2005237541A1 (en) | 2005-11-10 |
| CA2564134A1 (en) | 2005-11-10 |
| RU2006141653A (ru) | 2008-06-10 |
| WO2005105072A2 (en) | 2005-11-10 |
| CN101022779A (zh) | 2007-08-22 |
| CN101022779B (zh) | 2010-12-08 |
| MXPA06012426A (es) | 2007-03-28 |
| ZA200609821B (en) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20065422L (no) | Avlevering av anti-sopplegemiddel | |
| BR0313343A (pt) | Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal | |
| FR2892023A1 (fr) | Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale | |
| DK1126830T3 (da) | Farmaceutiske præparater til ekstern anvendelse indeholdende ikke-steroide anti-inflammatoriske og analgetiske midler | |
| NO20040934D0 (no) | Plaster for behandling av dysfunksjoner og forstyrrelser i negler som innbefatter sertaconazol | |
| BRPI0415953B8 (pt) | formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada | |
| BR0314450A (pt) | Sais de ácido borÈnico com adição de uma base farmaceuticamente aceitável, formulação farmacêutica, e uso dos referidos sais para preparar uma formulação farmacêutica | |
| JPH06211651A (ja) | 爪白癬治療用組成物 | |
| BRPI0513819A (pt) | inibidores de hsp90 | |
| BRPI0518898A2 (pt) | composto, processo para sua preparaÇço, composiÇço farmacÊutica, mÉtodo para tratamento e uso do composto | |
| AU2017251098B2 (en) | Dermocosmetic composition, production process of the topical composition, method for strengthening fragile nails and use of the composition | |
| US8962668B2 (en) | Treatment of length dependent neuropathy | |
| BRPI0513857A (pt) | inibidores de hsp90 | |
| CN106535936A (zh) | 治疗手足综合征及与其相关的症状的方法 | |
| US20080193508A1 (en) | Local anti-infective agent for treatment of nail fungal infections | |
| US20150313896A1 (en) | Method for treating cell proliferation disorders | |
| JP2013520483A5 (enExample) | ||
| BR0011880A (pt) | Método para o tratamento de condições co-mórbidas associadas com obesidade, composto, produto, uso de um composto, e, composição farmacêutica | |
| WO2010057117A3 (en) | Topical transdermal drug delivery compositions | |
| BR0305070A (pt) | Uso de derivado amida de ge 2270 fator a3 para tratamento da acne | |
| US20140079804A1 (en) | Compositions and methods for treatment of infections | |
| EP1962836B1 (en) | Treatment of length dependent neuropathy | |
| US20200009253A1 (en) | Compositions and Methods for Treatment of Infections | |
| EP3119403B1 (fr) | Composition à base d'acides carboxyliques et son application pour le traitement des hyperkératoses | |
| RU2012141024A (ru) | Композиция для лечения грибка ногтей |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |